{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fmumbai-smart-news.simplecast.com%2Fepisodes%2Fthe-covaxin-vaccine-dilemma-q8qlC8Y8","width":444,"version":"1.0","type":"rich","title":"The Covaxin vaccine dilemma ","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/1dee3433-5b28-4b8e-b215-723dc06e7835/8c1a0b37-212f-4f41-97ff-3406d8f460bb/36963975.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c01e90d1-3c42-428b-acae-dcbf5cb3cc6c\" height=\"200\" width=\"100%\" title=\"The Covaxin vaccine dilemma \" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":" \n\nCurrently, data from both efficacy and safety follow-up of Covaxin's Phase III trial is being analyzed and going to be made public soon. For those who have taken Covaxin so far, Tune in with Rohini and Sachin for a little perspective on whether you should be worried about the results from the final trial. \n"}